APA Corporation enters its May 7 Q1 results sitting in an unusual position: short sellers have been stepping back sharply, options traders are leaning constructive, and the Street — while not enthusiastic — has been quietly lifting targets ahead of the print.
The clearest development in positioning is the sustained short-covering that has run through April. Short interest has fallen roughly 17% over the past month to 7.0% of the free float, down from a peak of just over 8.4% at the start of April. That is still a meaningful short base, but the direction of travel is unambiguous — nearly 5 million shares have been returned to lenders since late March. Availability in the lending pool remains loose, with a cost to borrow of just 0.40% and borrow availability well off stressed levels; the 52-week peak in lending utilisation was 31.9%, against a current 10.7%. That combination — shrinking short interest, cheap borrow, and ample availability — describes a market that is not pressing an aggressive bearish case heading into the quarter.
Options positioning reinforces the cautious-rather-than-bearish read. The put/call ratio sits at 0.52, essentially in line with its 20-day average of 0.52, with a z-score of -0.31. That is close to neutral, but the directional drift over the past three weeks is worth noting: the PCR ran consistently above 0.55 in early April, during the peak of tariff anxiety, and has since eased toward the low 0.50s as the stock recovered. The 52-week low on the PCR is 0.44, the high is 0.84 — today's reading sits in the lower half of that range, suggesting options traders are comfortable running relatively less downside protection than usual.
The Street has been unanimous on one thing this month: targets are moving higher. Seven analysts raised price targets between March and late April, though none upgraded their underlying rating — most remain at Neutral, Hold, or Equal-Weight. UBS and Citi both moved targets to $45, Morgan Stanley lifted to $43 despite keeping an Underweight, and Barclays upgraded from Underweight to Equal-Weight in late March. Wells Fargo made the largest arithmetic move, nearly doubling its target from $21 to $39. The consensus message is that APA has re-rated higher on improved operational execution and the Egypt expansion — but the Street is not yet ready to call it a Buy at these levels. With APA trading at $41.48 against a mean target that is clustered between $36 and $45, upside to consensus is limited unless Q1 surprises materially. Valuation looks undemanding on enterprise value: EV/EBITDA is running at 3.4x, down roughly 0.3x over 30 days, and the earnings yield factor ranks in the 84th percentile. The EPS momentum story is also genuinely strong — the 30-day momentum score lands in the 88th percentile, the 90-day reading at the 94th.
The earnings history adds context without offering comfort. Over the four most recent quarterly prints, APA moved between +1.7% and +10.0% on the day, with five-day follow-through extending the gains in each case — the average next-day move across those four quarters was roughly +7%, and the five-day move averaged around +13%. The range has been skewed heavily to the upside in recent quarters. That does not mean a repeat is likely, but it does mean the stock has rewarded patience at recent prints. The ORTEX short score of 45.6 places APA in a moderate zone — neither an extreme squeeze candidate nor a runaway short thesis.
Institutional flows provide a quieter supporting signal. BlackRock added 6.6 million shares through to April 30, State Street added 1.5 million, Goldman Sachs added 2.2 million in Q1, and Dimensional added 1.3 million. Vanguard and Fidelity also added during the period. No major holder appears to be exiting ahead of the print. Peer performance on the week was broadly positive for the E&P group — OVV gained nearly 8%, CHRD and SM both added around 6-7%, and APA's own 7.3% weekly gain tracks the sector recovery closely. The one outlier is COP, which was flat to slightly negative on the week, suggesting some divergence between large integrated names and the pure-play exploration complex.
What to watch on the May 7 call is how management frames the Egypt land award and whether the free cash flow trajectory for the remainder of 2026 changes the conversation around capital return — that is the variable the bulls and bears are most actively debating.
See the live data behind this article on ORTEX.
Open APA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
